Champions Oncology Inc Stock
Your prediction
Champions Oncology Inc Stock
We can see a decrease in the price for Champions Oncology Inc. Compared to yesterday it has lost €0.000 (-2.680%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Champions Oncology Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Champions Oncology Inc in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Champions Oncology Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | -2.680% | -2.242% | -15.340% | -14.510% | -24.828% | -22.832% | -50.455% |
| Heron Therapeutics Inc. | -30.070% | -35.714% | -23.680% | -74.673% | -74.309% | -81.771% | -97.186% |
| Evolus Inc | -1.880% | 23.433% | 12.001% | 29.160% | 18.495% | -25.770% | -32.021% |
| Rhythm Pharmaceuticals | -0.500% | 10.615% | 4.211% | 28.571% | 5.882% | 341.964% | 768.421% |
News
Hawaiian Electric Industries Q2 Earnings Call Highlights
Key Points
- Interested in Hawaiian Electric Industries, Inc.? Here are five stocks we like better.
- Hawaiian Electric reported $123.2 million in Q2 net income, or $0.71 per share, boosted by a
Champions Oncology Q4 Earnings Call Highlights
Key Points
- Interested in Champions Oncology, Inc.? Here are five stocks we like better.
- Record fiscal 2026 performance: Revenue reached $59.4 million, up from the prior year, and adjusted
West Pharmaceutical Services Q2 Earnings Call Highlights
Key Points
- Interested in West Pharmaceutical Services, Inc.? Here are five stocks we like better.
- West Pharmaceutical Services beat second-quarter expectations, with revenue up 13% organically